1. Abrutyn E. Botulism. In: Petersdorf RG, Adams RD, Braunwald E, Isselbacher KJ, Martin JB, Wilson JD, ed(s). Principles of Internal Medicine. 14th ed. McGraw-Hill New York 1998: 904-5.
2. Todd ECD. Costs of acute bacterial foodborne disease in
Canada and the United States. Int J Food Microbiol 1989; 9: 313-26.
3. Kerner J. Neue Beobachtungen über die in Würtemburg so haüfig vorfallen Vergiftung durch den Genuss gerauchter Würst. Tubingen 1820. In: Damon SR, ed. Infections and Food Intoxications. Baltimore: Williams Wilkins 1928: 67.
4. Young JH. Botulism and the ripe olive scare of 1919-1920. Bull Hist Med 1976; 50: 372-91.
5. van Ermengen E. Ueber einen neuen anaeroben Bacillus und seine Beziehungen zum Botulismus. Z Hyg Infekt 1897; 26: 1¬56.
6. Landman G. Ueber die Ursache der Darmstadter Bohnen
Vergiftung. Hyg Rundsch 1904; 14: 449-52.
7. Davis JB, Mattman LH, Wiley M. Clostridium botulinum in a
fatal wound infection. JAMA 1951; 146: 646-8.
8. Midura TF, Arnon SS. Infant botulism: Identification of Clostridium botulinum and its toxin in faeces. Lancet 1976; 2:
934-6.
9. Chia JK, Clark JB, Ryan CA, et al. Botulism in an adult associated with foodborne intestinal infection with Clostridium
Botulinum. N Eng J Med 1986; 315: 239-41.
10. Lamanna C, Mc Elroy OE, Eklund HW. The purification and crystallization of Clostridium botulinum type A toxin. Science 1946; 103: 613-4.
11. Cato EP, Geroge WL, Finegold SM. Genus Clostridium
praemozski 1880. In: Smeath PHA, Mair NS, Sharpe ME,
ed(s). Bergey's Manual of Systematic Bacteriology. v. 2.
Baltimore: Williams Wilkins 1986: 1141-200.
12. Eklund MW, Poysky FT, Habig WH. Bacteriophages and plasmids in Clostridium botulinum and Clostridium tetani and
Turgut ÖzalTıp Merkezi Dergfci5(ı):1998
Ekmekçi H, et al.
Botulism
their relationship to the production of toxin. In: Simpson LL, ed. Botulinum Neurotoxin and Tetanus Toxin. San Diego:
Academic Press 1989: 25-51.
13. Hatheway CL. Botulism: the present status of the disease. Curr Top Microbiol Immunol 1995; 195: 55-7.
14. Shaffer N, Wainwright RB, Middaugh PJ, et al. Botulism
among Alaska Natives. The role of changing food preparation and consumption practices. West J Med 1990; 153: 390-3.
15. Gao QY, Huang YF, Wu JG, et al. A review of botulism in China. Biomed Environ Sci 1990; 3: 326-36.
16. Centers for Disease Control and Prevention. Botulism and
commercial pot pie-California. MMWR 1983; 32: 39-40, 45.
17. Hughes JM. Botulism. In: Scheld WM, Whitley RJ, Durack
DT,ed(s). Infections of the Central Nervous System. New
York: Raven Press 1991: 589-602.
18. Smith LDS. The occurrence of Clostridium botulinum and clostridium tetani in the soil of the United States. Health Lab
Sci 1978; 15: 74-80.
19. Weber JT, Goodpasture HC, Alexander H, et al. Wound botulism in a patient with a tooth abscess: case report and review. Clin Infect Dis 1993; 16: 635-9.
20. Midura TF, Snowden S, Wood RM, et al. Isolation of
Clostridium botulinum from honey. J Clin Microbiol 1979; 9:
282-3.
21. Spika JS, Shaffer N, Hargrett-Bean N, et al. Infant botulism in the United States: An epidemiologic study of cases occuring outside of California. Am J Public Health 1983; 73: 1385-8.
22. Hurst DL, Marsh WW. Early severe infantile botulism. J
Pediatr 1993; 122: 909-11.
23. Suen JC, Hatheway CL, Steigerwalt AG, et al. Genetic confirmation of the identities of neurotoxigenic Clostridium baratii and Clostridium butyricum implicated as agents of
human botulism. J Clin Microbiol 1988; 26: 2191-2.
24. Mac Donald KL, Cohen ML, Blake PA. The changing
epidemiology of adult botulism in the United States. Am J Epidemiol 1986; 124: 794-9.
25. McCroskey LM, Hatheway CL, Woodruff BA, et al. Type F
botulism due to neurotoxigenic Clostridium baratii from an unknown source in an adult. J Clin Microbiol 1991; 29: 2618¬20.
26. Centers for Disease Control and prevention. Botulism in the United States, 1899-1973. Handbook for Epidemiologist, Clinicians, and Laboratory Workers. Atlanta: DHEW 1974.
27. Tacket CO, Shandera WX, Mann JM, et al. Equine antitoxin use and other factors that predict outcome in type A foodborne
botulism. Am J Med 1984; 76: 794-8.
28. Hauschild AHW. Clostridium botulinum. In: Doyle MP, ed.
Foodborne Bacterial Pathogens. New York: Marcel Dekker
1989: 112-89.
29. Tacket CO, Rogawski MA. Botulism. In: Simpson LL, ed. Botulinum Neurotoxin and Tetanus Toxin. San Diego:
Academic Press; 1989: 351-78.
30. Patten J. Neurological Differential Diagnosis; 2nd ed. Glaskow: Springer-Verlag 1996.
31. Critchley EMR, Mitchell JD. Human Botulism. Br J Hosp
Med. 1992; 43: 290-2.
32. Maselli RA, Burnett ME, Tonsgard JH. In vitro microelectrode study of neuromuscular transmission in a case of botulism. Muscle Nerve 1992; 15: 273-8.
33. Terranova W, Palumbo JN, Berman JG. Ocular findings in
botulism type B. JAMA 1979; 241: 475-7.
34. Friedman DI, Fortanasce VN, Sadun AA. Tonic pupils as a
result of botulism. Am J Ophthalmol 1990; 109: 236-7.
35. Simcock PR, Kelleher S, Dunne JA. Neuro-ophthalmic findings in botulism type B. Eye 1994; 8: 646-8.
36. Woodruff BA, Griffin PM, McCCroskey LM, et al. Clinical
and laboratory comparison of botulism from toxin types A, B, and E in the United States 1975-1988. J Infect Dis 1992; 166:
1282-6.
37. Hughes JM, Blumenthal JR, Merson MH, et al. Clinical
features of types A and B foodborne botulism. Ann Intern Med
1981; 95: 442-5.
38. Vita G, Girlanda P, Puglisi RM, et al. Cardiovascular-reflex testing and single fiber electromyography in botulism. A
longitudinal study. Arch Neurol 1987; 44: 202-6.
39. Griffin PM, Hatheway CL, Rosenbaum, et al. Endogenous antibody production to botulinum toxin in an adult with intestinal colonization botulism an underlying Crohn's disease. J Infect Dis 1997; 175: 633-7.
40. Weber JT, Hibbs RG, Darwish A, et al. A massive outbreak of type E botulism associated with traditional salted fish in Cairo.
J Infect Dis 1993; 167: 451-4.
41. Colerbatch JG, Wolff AH, Gilbert RJ, et al. Slow recovery
from severe foodborne botulism. Lancet 1989; 2: 1216-17.
42. Cornblath DR, Sladky JT, Sumner AJ. Clinical
electrophysiology of infantile botulism. Muscle Nerve 1983; 6:
448-52.
43. Oken A, Barnes S, Rock P, et al. Upper airway obstruction and
infant botulism. Anest Analg 1992; 75: 136-8.
44. Schreiner MS, Field E, Ruddy R. Infant botulism: A review of 12 years experience at the Children's Hospital of Philadelphia.
Pediatricss 1991; 87: 159-65.
45. Glauser TA, Maquire HC, Sladky JT. Relapse of infant
botulism. Ann Neurol. 1990; 28: 187-9.
46. Thomas DG. Infant botulism: a review in South Australia
(1980-89). J Paediatr Child Health 1993; 29: 24-6.
47. Elston HR, Wang M, Loo LK. Arm abscesses caused by
Clostridium botulinum. J Clin Microbiol 1991; 29: 2678-9.
48. Kudrow DB, Henry DA, Haake DA, et al. Botulism associated with Clostridium botulinum sinusitis after intranasal cocaine
abuse. Ann Inter Med 1988; 109: 984-5.
49. Kuruoglu R, Cengiz B, Tokçaer A. Botulism with sensory symptoms diagnosed by neuromuscular transmission studies associated with edrophonium responsiveness. Electromyogr
Clin Neurophysiol 1996; 36: 477-8.
50. Edell TA, Sullivan CP, Osborn KM, et al. Wound botulism
associated with a positive Tensilon test. West J Med 1983; 139: 218-9.
51. Cherington M. Botulism. Semin Neurol 1990; 10: 27-31.
52. Dunbar EM. Botulism. J Infect 1990; 20: 1-3.
53. Dowell VR, McCroskey LM, Hatheway CL, et al.
Coproexamination for botulinal toxin and Clostridium
Journal ofTurgut Özal Medical Center 5(1):1998
95
Botulizm
H. Ekmekçi ve ark.
botulinum. A new procedure for laboratory diagnosis of
botulism. JAMA; 238: 1829-32.
54. Notermans S, Nagel J. Assays for botulinum and tetanus toxins. In: Simpson LL, ed. Botulinum Neurotoxin and Tetanus Toxin. San Diego: Academic Press 1989: 319-31.
55. Notermans SHW, Wokke JHJ, van den Berg LH. Botulism and Guillain-Barre syndrome. Lancet 1992; 340: 303.
56. Sanders DB. Electrophysiologic study of disorders of neuromuscular transmission. In: Aminoff MJ ed. Electrodiagnosis in Clinical Neurology. 3rd ed. New York:
Churchill Livingstone 1992: 347-8.
57. Gutman L, Prott L. Pathophysiologic aspects of human
botulism. Arch Neurol 1976; 33: 175-9.
58. Schiller HH, Stalberg E. Human botulism studied with single-fiber electromyography. Arch Neurol 1974; 35: 346
59. Gutierrez AR, Bodensteiner J, Gutmann J. Electrodiagnosis of
infantile botulism. J Child Neurol 1994; 9: 362-5.
60. Barrett DH. Endemic food-borne botulism: Clinical experience, 1973-1986. Alaska Med. 1991; 33: 101-8.
61. Frankovich TL, Arnonm SS. Clinical trial of botulism immune
globulin for infant botulism. West J Med 1991; 154:103.
62. Wilson R, Morris JG, Snyder JD, et al. Clinical characteristics of infant botulism in the United States: A study of the non-
California cases. Pediatr Infect Dis 1982; 1: 148-50.
63. Kaplan JE, Davis LE, Narayan V, et al. Botulism, type A, and treatment with guanidine. Ann Neurol 1979; 6: 69-71.
64. Wilcox PG, Morrison NJ, Pardy Rl. Recovery of the ventilatory and upper airway muscles and exercise performance after type A botulism. Chest 1990; 98: 620-6.
65. Cohen FL, Hardin SB, Nehring SB, et al. Physical and psychosocial health status 3 years after catastrophic illness-
botulism. Issue Mental Health Nurs 1988; 9: 387-98.
66. Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias, and hemifacial spasm. J Neurol
Neurosurg Psychiatr 1990; 53: 633-9.
67. Jankovic J, Brin M. Therapeutic uses of botulinum toxin. N
Engl J Med 1991; 324: 1186-94.
68. Jankovic J, Schwartz K. Botulinum toxin treatment of tremors.
Neurology 1991; 41: 1185-8.
69. Townes JM, Cieslak PR, Hatheway CL, et al. An outbreak of type A botulism associated with a commercial cheese sauce.
Ann Intern Med 1996; 125: 558-60.
70. Lo Vecchio F, Jacobson S. Approach to generalised weakness and peripheral neuromuscular disease. Emerg Med Clin North
Am 1997; 15: 605-23.
71. Beller M, Middaugh JP. Repeated type E botulism in an
Alaskan Eskimo. N Engl J Med 1990; 322: 855.
Thank you for copying data from http://www.arastirmax.com